These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4021088)

  • 1. [Effects of amrinone on hemodynamics, oxygen consumption and plasma catecholamine levels in anesthetized dogs].
    Kosugi I; Gonda T; Okada K; Tajimi K; Moriyasu N; Fukatsu O
    Masui; 1985 Apr; 34(4):429-33. PubMed ID: 4021088
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of amrinone on hemodynamics, oxygen consumption and plasma catecholamine levels in endotoxin injected dogs].
    Kosugi I; Tajimi K; Gonda T; Fukatsu O; Ueda S
    Masui; 1985 Sep; 34(9):1223-8. PubMed ID: 4087357
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of amrinone, a new non-digitalic positive inotropic agent, on the efficiency and coronary circulation of the heart].
    Bárcenas L; Kabela E
    Arch Inst Cardiol Mex; 1984; 54(5):431-40. PubMed ID: 6517640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute haemodynamic effects of intravenous amrinone in chronic congestive heart failure.
    Bahl VK; Khalilullah M
    Indian Heart J; 1984; 36(6):369-74. PubMed ID: 6535755
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of the cardiotonic imazodan (CI-914) on myocardial and peripheral hemodynamics in the anesthetized dog.
    Steffen RP; Eldon CM; Evans DB
    J Cardiovasc Pharmacol; 1986; 8(3):520-6. PubMed ID: 2425167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS
    Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effects of amrinone on hemodynamics and myocardial oxygen balance in anesthetized dogs with experimental left ventricular failure by ventricular fibrillation].
    Fujigaki T; Hashiguchi Y; Nakahara I; Yukinari T; Haseba S; Gotoh Y
    Masui; 1987 Apr; 36(4):561-7. PubMed ID: 3613066
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine.
    Boncyk J; Redon D; Rusy B
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):347-54. PubMed ID: 6463363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-glycoside cardiotonic agents].
    Landmann H; Löwe H
    Pharmazie; 1986 Mar; 41(3):169-72. PubMed ID: 2872686
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies with beta 2 adrenoceptor agonists in heart failure.
    Dawson JR; Bayliss J; Norell MS; Canepa-Anson R; Kuan P; Reuben S; Poole-Wilson PA; Sutton GC
    Eur Heart J; 1982 Dec; 3 Suppl D():135-41. PubMed ID: 6130947
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
    Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
    Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amrinone (50 micrograms.kg-1.min-1) does not impair regional myocardial tissue metabolism during the 40%-decrease of left anterior descending coronary flow].
    Tateyama T; Suzuki H; Fukuyama H; Fujiwara R; Abe Y; Okutsu Y
    Masui; 1996 Feb; 45(2):148-52. PubMed ID: 8865700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effects of amrinone and caffeine on cardiac contractility: positive versus negative inotropy.
    Malécot CO; Katzung BG
    Proc West Pharmacol Soc; 1984; 27():11-3. PubMed ID: 6494142
    [No Abstract]   [Full Text] [Related]  

  • 16. Inotropic and vasopressor agents.
    Smith LD; Oldershaw PJ
    Br J Anaesth; 1984 Jul; 56(7):767-80. PubMed ID: 6375707
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of amrinone on the cardiotoxicity induced by adriamycin in the rat].
    Bernardini C; Romanini A; Danesi R; Del Tacca M
    G Ital Chemioter; 1985; 32(1):35-7. PubMed ID: 3830791
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
    Rohde E; Wiesner B; Muschick P
    Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog.
    Einzig S; Rao GH; Pierpont ME; White JG
    Can J Physiol Pharmacol; 1982 Jun; 60(6):811-8. PubMed ID: 7116227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.